Word: r
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
...Amgen (AMGN) is still growing rapidly unlike most Big Pharma companies. Its biotech business is producing novel medical treatments that have kept Amgen's sales solid while old line drug companies have been shrinking. In the fourth quarter, Amgen spent $770 million on R&D and needs to do so to both further refine and develop new drugs. The firm is not cutting back on the essentials for keeping its product mix strong simply because the economy is weak. Amgen expects to bring in $15 billion in revenue this year, about flat with 2008. Amgen has several products in trials...
...Again” every night might even enjoy it. But for the rest of us, we’ll have to hope that suffering really does make you stronger. If so, watching this video is as good as working out. —Chris R. Kingston
...workload among remaining faculty or bringing in high-level visiting professors. Kennedy School Professor of Government Graham T. Allison ’62 noted that the school is also attracting people leaving the Bush administration, including Meghan L. O’Sullivan, a former deputy national security adviser, and R. Nicholas Burns, former undersecretary of state for political affairs. Polk suggested the Kennedy School’s administration accelerate the searches that are currently underway for high-level faculty positions. “The student body would have liked it if the administration had worked to bring in some rock...
...Asani explains. “This would be in keeping with the recently released recommendations of the Task Force on the Arts.”“The images are able to emphasize something that is normally absent for typical media reports,” says David R. Odo, Harvard lecturer on anthropology and visiting curator at the Peabody Museum of Archaeology and Ethnology. “[But] there is no single form of knowledge sufficient to capture or understand human experience. We need to use many forms. Photography, and indeed the arts more generally, can contribute to this...
Professor Jeff W. Lichtman and his team painstakingly craft their colorful masterpieces—but their paintbrush is the genome, and their canvass the brain. Lichtman and his colleague Joshua R. Sanes, both molecular and cellular biology professors at Harvard, are mapping neurons with a pioneering method, dubbed “brainbow” for its psychedelic appearance. Already, the technique—recently honored with a Nobel Prize in chemistry—is shedding light on the development of the human mind, and how disorders such as Alzheimer’s and even anxiety alter the brain...